MICHAEL BRAUN to Disease-Free Survival
This is a "connection" page, showing publications MICHAEL BRAUN has written about Disease-Free Survival.
Connection Strength
0.104
-
Endocrine Therapy Response and 21-Gene Expression Assay for Therapy Guidance in HR+/HER2- Early Breast Cancer. J Clin Oncol. 2022 08 10; 40(23):2557-2567.
Score: 0.039
-
Early Adaptation of Colorectal Cancer Cells to the Peritoneal Cavity Is Associated with Activation of "Stemness" Programs and Local Inflammation. Clin Cancer Res. 2021 02 15; 27(4):1119-1130.
Score: 0.035
-
Comparison of Neoadjuvant Nab-Paclitaxel+Carboplatin vs Nab-Paclitaxel+Gemcitabine in Triple-Negative Breast Cancer: Randomized WSG-ADAPT-TN Trial Results. J Natl Cancer Inst. 2018 06 01; 110(6):628-637.
Score: 0.030